Celgene, Acceleron to file MDS therapy in the EU, US
admin 2nd July 2018 Uncategorised 0Celgene and Acceleron Pharma are preparing to file their experimental myelodysplastic syndromes (MDS) therapy on both sides of the Atlantic on the back of promising data from a late-stage study. More: Celgene, Acceleron to file MDS therapy in the EU,
read more